AJ

Alison Jones

ML Mission Therapeutics Limited: 20 patents #3 of 17Top 20%
CL Cellzome Limited: 3 patents #18 of 59Top 35%
Johnson & Johnson: 2 patents #3,442 of 7,810Top 45%
Overall (All Time): #170,097 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
11993595 Compounds Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2024-05-28
11945797 1-cyano-pyrrolidine derivatives as dub inhibitors Mark Ian Kemp, Martin Lee Stockley, Michael David Woodrow 2024-04-02
11472798 Compounds Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2022-10-18
11390584 1-cyano-pyrrolidine compounds as USP30 inhibitors Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2022-07-19
11352339 1-cyano-pyrrolidine derivatives as DUB inhibitors Mark Ian Kemp, Martin Lee Stockley, Michael David Woodrow 2022-06-07
11319287 Cyanopyrrolidines as dub inhibitors for the treatment of cancer Mark Ian Kemp, Martin Lee Stockley 2022-05-03
11306096 4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancer Mark Ian Kemp, Martin Lee Stockley, Michael David Woodrow 2022-04-19
11236092 Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors Mark Ian Kemp, Martin Lee Stockley, Michael David Woodrow 2022-02-01
11066365 1-cyano-pyrrolidine compounds as USP30 inhibitors Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2021-07-20
11053198 1-cyano-pyrrolidine compounds as USP30 inhibitors Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2021-07-06
11014912 Cyanopyrrolidine derivatives with activity as inhibitors of USP30 Martin Lee Stockley, Mark Ian Kemp, Andrew Madin, Michael David Woodrow 2021-05-25
10774078 Compounds Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2020-09-15
10689345 1-cyano-pyrrolidine compounds as USP30 inhibitors Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2020-06-23
10683269 2-cyanoisoindoline derivatives for treating cancer Karl Richard Gibson, Mark Ian Kemp, Andrew Madin, Martin Lee Stockley, Gavin Alistair Whitlock +2 more 2020-06-16
10669234 Cyanopyrrolidines as dub inhibitors for the treatment of cancer Mark Ian Kemp, Martin Lee Stockley 2020-06-02
10654853 Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors Mark Ian Kemp, Martin Lee Stockley, Michael David Woodrow 2020-05-19
10640498 Compounds Karl Richard Gibson, Mark Ian Kemp, Andrew Madin, Martin Lee Stockley, Gavin Alistair Whitlock +1 more 2020-05-05
10392380 Compounds Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2019-08-27
10343992 1-cyano-pyrrolidine compounds as USP30 inhibitors Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock 2019-07-09
9926307 Compounds Mark Ian Kemp, Martin Lee Stockley, Karl Richard Gibson, Gavin Alistair Whitlock, Andrew Madin 2018-03-27
9655897 Heterocyclyl pyrimidine analogues as TYK2 inhibitors Richard John Harrison, Nigel Ramsden, Jeremy Major, Adeline Morel, Laura Convery +3 more 2017-05-23
9296725 Heterocyclyl pyrimidine analogues as TYK2 inhibitors Richard John Harrison, Nigel Ramsden, Jeremy Major, Adeline Morel, Laura Convery +3 more 2016-03-29
8692017 Carbon linked modulators of gamma-secretase Chih Yung Ho, Yan Zhang, Svenja Burckhardt 2014-04-08
8247610 Amine linked modulators of γ-secretase Chih Yung Ho, Yan Zhang, Umar Maharoof, John Harrison, Jeremy Major +1 more 2012-08-21